BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20351979)

  • 1. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma.
    Shaib W; Mitchell K; Saif MW
    Yale J Biol Med; 2010 Mar; 83(1):27-33. PubMed ID: 20351979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.
    Case CC; Wirfel K; Vassilopoulou-Sellin R
    Med Oncol; 2002; 19(3):181-7. PubMed ID: 12482130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
    Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal].
    Brichard B; Fiasse R; Buts JP; Clapuyt P; Maes M; Rahier J; Cornu G
    Acta Gastroenterol Belg; 1990; 53(2):188-97. PubMed ID: 2176428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of VIPoma in a female patient.
    Remme CA; de Groot GH; Schrijver G
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):93-9. PubMed ID: 16357627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
    Schizas D; Mastoraki A; Bagias G; Patras R; Moris D; Lazaridis II; Arkadopoulos N; Felekouras E
    J BUON; 2019; 24(2):415-423. PubMed ID: 31127985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VIPoma with expression of both VIP and VPAC1 receptors in a patient with WDHA syndrome.
    Nakayama S; Yokote T; Kobayashi K; Hirata Y; Hiraiwa T; Komoto I; Miyakoshi K; Yamakawa Y; Takubo T; Tsuji M; Imamura M; Hanafusa T
    Endocrine; 2009 Apr; 35(2):143-6. PubMed ID: 19184565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasoactive polypeptide-producing pancreatic carcinoma].
    Gréczi K; Küronya P; Krutsay M
    Orv Hetil; 1995 Sep; 136(37):2009-11. PubMed ID: 7566933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Irreversible Electroporation for Pancreatic VIPoma: A Case Report.
    Niu L; Li J; Zeng J; Fang G; Zhou L; Xu K; Zhang K
    Pancreas; 2017 Jan; 46(1):135-137. PubMed ID: 27977628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of pancreatic cholera: a case report.
    Kirkpatrick AW; Hanna SS; Skinner BA
    Can J Surg; 1996 Apr; 39(2):155-8. PubMed ID: 8769928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic VIPomas from China: Case reports and literature review.
    Chen C; Zheng Z; Li B; Zhou L; Pang J; Wu W; Zheng C; Zhao Y
    Pancreatology; 2019 Jan; 19(1):44-49. PubMed ID: 30391116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome.
    Pratz KW; Ma C; Aubry MC; Vrtiska TJ; Erlichman C
    Mayo Clin Proc; 2005 Jan; 80(1):116-20. PubMed ID: 15667039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metastasizing pancreatic vipoma. Its diagnosis and therapy with the somatostatin analog octreotide].
    Scheffold N; Arnold R; Cyran J
    Dtsch Med Wochenschr; 1995 Oct; 120(43):1463-7. PubMed ID: 7588006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report.
    Nilubol N; Freedman EM; Quezado MM; Patel D; Kebebew E
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3564-3567. PubMed ID: 27583474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIPomas: an update in diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Safioleas M; Mallas E; Polyzos A
    Hepatogastroenterology; 2005; 52(64):1259-65. PubMed ID: 16001675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
    Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
    Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metastatic Vipoma by liver transplantation.
    Bramley PN; Lodge JP; Losowsky MS; Giles GR
    Clin Transplant; 1990 Oct; 4(5 part 1):276-8; discussion 279. PubMed ID: 10150088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
    Flückiger A; Schlup P
    Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
    Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
    Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical problem-solving. Needle in a haystack.
    Kapoor R; Moseley RH; Kapoor JR; Crapo LM; Saint S
    N Engl J Med; 2009 Feb; 360(6):616-21. PubMed ID: 19196679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.